Appendix B: Panel Roster and Financial Disclosures
Hepatitis C Virus
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Meena Bansal | Icahn School of Medicine at Mount Sinai | None | N/A |
| Greer Burkholder | The University of Alabama at Birmingham Heersink School of Medicine | Merck Foundation Cepheid | Research Support |
| Emily Cartwright | Centers for Disease Control and Prevention | None | N/A |
| Arthur Kim | Harvard Medical School | Kintor Pharmaceuticals | Data Monitoring Committee |
| Nina Kim | University of Washington School of Medicine and School of Public Health | Gilead Sciences (FOCUS Grant) | Research Support (paid to institution) |
| Kristen Marks | Weill Cornell Medicine | Gilead Sciences | Consultant |
| Immorna | Data Safety Monitoring Board Member | ||
| Novo Norodisk | Data Safety Monitoring Board Member | ||
| Viiv | Research Support (paid to institution) | ||
| Susanna Naggie | Duke University School of Medicine | Bristol Myers Squibb | Adjudication Committee |
| Pardes Biosciences, Inc. | Consultant | ||
| National Institutes of Health | Research Support | ||
| Vir Biotechnology | Advisory Board | ||
| Gilead Sciences | Research Support | ||
| Personal Health Insights, Inc. | Data Safety Monitoring Board Chair/Member Research Support | ||
| FHI 360 | Event Adjudication | ||
| Merceditas Villanueva* | Yale University School of Medicine | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. | |||
Download Guidelines
- Section Only PDF (20.18 KB)
- Full Guideline PDF (6.08 MB)
- Tables Only PDF (918.31 KB)